Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Emergency Medicine
Volume 2015 (2015), Article ID 483153, 2 pages
http://dx.doi.org/10.1155/2015/483153
Case Report

Profound Hypoglycemia with Ecstasy Intoxication

Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA

Received 8 October 2014; Accepted 10 January 2015

Academic Editor: Kalpesh Jani

Copyright © 2015 Perliveh Carrera and Vivek N. Iyer. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Kalant, “The pharmacology and toxicology of ‘ecstasy’ (MDMA) and related drugs,” Canadian Medical Association Journal, vol. 165, no. 7, pp. 917–928, 2001. View at Google Scholar · View at Scopus
  2. H. Williams, L. Dratcu, R. Taylor, M. Roberts, and A. Oyefeso, “‘Saturday night fever’: ecstasy related problems in a London accident and emergency department,” Journal of Accident and Emergency Medicine, vol. 15, no. 5, pp. 322–326, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. G. N. Nadkarni, S. S. Hoskote, J. Piotrkowski, and N. Annapureddy, “Serotonin syndrome, disseminated intravascular coagulation, and hepatitis after a single ingestion of MDMA in an Asian woman,” American Journal of Therapeutics, vol. 21, no. 4, pp. e117–e119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Ben-Abraham, O. Szold, V. Rudick, and A. A. Weinbroum, ““Ecstasy” intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting,” European Journal of Emergency Medicine, vol. 10, no. 4, pp. 309–313, 2003. View at Google Scholar · View at Scopus
  5. H. Montgomery and S. Myerson, “3,4-Methylenedioxymethamphetamine (MDMA, or ‘ecstasy’) and associated hypoglycemia,” The American Journal of Emergency Medicine, vol. 15, no. 2, p. 218, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. M. L. Soto-Montenegro, J. J. Vaquero, C. Arango, G. Ricaurte, P. García-Barreno, and M. Desco, “Effects of MDMA on blood glucose levels and brain glucose metabolism,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, no. 6, pp. 916–925, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. N. L. Benowitz, R. T. Jones, and C. B. Lerner, “Depression of growth hormone and cortisol response to insulin-induced hypoglycemia after prolonged oral delta-9-tetrahydrocannabinol administration in man,” Journal of Clinical Endocrinology and Metabolism, vol. 42, no. 5, pp. 938–941, 1976. View at Publisher · View at Google Scholar · View at Scopus
  8. Substance Abuse and Mental Health Services Administration, Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA), Substance Abuse and Mental Health Services Administration, Rockville, Md, USA, 2013, http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.htm#tab8.1.
  9. Substance Abuse and Mental Health Services Administration DAWN, National Estimates of Drug-Related Emergency Department Visits, HHS Publication No. (SMA) 13-4760, DAWN Series D-39, Substance Abuse and Mental Health Services Administration, Rockville, Md, USA, 2013.
  10. “From 2005-11, ecstasy-related hospital ER visits up 128 percent,” 2013, http://www.upi.com/Health_News/2013/12/05/From-2005-11-ecstasy-related-hospital-ER-visits-up-128-percent/UPI-96611386226410/.